Assembly Biosciences Analyst Ratings
Assembly Biosciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2022 | 115.83% | Mizuho | $14 → $3 | Maintains | Buy |
| 10/24/2022 | 43.88% | Truist Securities | $11 → $2 | Downgrades | Buy → Hold |
| 04/01/2022 | 763.31% | Truist Securities | $15 → $12 | Maintains | Buy |
| 09/13/2021 | 151.8% | HC Wainwright & Co. | → $3.5 | Initiates Coverage On | → Neutral |
| 09/02/2021 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 05/10/2021 | 403.6% | SVB Leerink | $8 → $7 | Maintains | Market Perform |
| 03/23/2021 | 475.54% | SVB Leerink | $9 → $8 | Downgrades | Outperform → Market Perform |
| 11/06/2020 | 619.42% | Jefferies | → $10 | Downgrades | Buy → Hold |
| 10/19/2020 | 3856.83% | Truist Securities | → $55 | Initiates Coverage On | → Buy |
| 07/08/2020 | 2633.81% | SVB Leerink | $36 → $38 | Maintains | Outperform |
| 10/16/2019 | 1338.85% | Mizuho | → $20 | Initiates Coverage On | → Buy |
| 10/08/2018 | 2921.58% | B. Riley Securities | $42 → $42 | Upgrades | Neutral → Buy |
| 08/08/2018 | 5223.74% | Baird | → $74 | Initiates Coverage On | → Outperform |
| 05/08/2018 | 2921.58% | B. Riley Securities | $45 → $42 | Maintains | Neutral |
| 04/13/2018 | — | Chardan Capital | Downgrades | Buy → Neutral | |
| 01/05/2018 | 2417.99% | B. Riley Securities | → $35 | Initiates Coverage On | → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 11/16/2022 | 115.83% | 瑞穗 | $14 → $3 | 維護 | 買 |
| 10/24/2022 | 43.88% | Truist證券 | $11 → $2 | 評級下調 | 購買→Hold |
| 04/01/2022 | 763.31% | Truist證券 | $15 → $12 | 維護 | 買 |
| 09/13/2021 | 151.8% | HC Wainwright公司 | → $3.5 | 開始承保 | →中性 |
| 09/02/2021 | — | 威廉·布萊爾 | 評級下調 | 跑贏→市場表現 | |
| 05/10/2021 | 403.6% | SVB Leerink | $8 → $7 | 維護 | 市場表現 |
| 03/23/2021 | 475.54% | SVB Leerink | $9 → $8 | 評級下調 | 跑贏→市場表現 |
| 11/06/2020 | 619.42% | 傑富瑞 | → $10 | 評級下調 | 購買→Hold |
| 10/19/2020 | 3856.83% | Truist證券 | → $55 | 開始承保 | →購買 |
| 07/08/2020 | 2633.81% | SVB Leerink | $36 → $38 | 維護 | 跑贏大盤 |
| 10/16/2019 | 1338.85% | 瑞穗 | → $20 | 開始承保 | →購買 |
| 10/08/2018 | 2921.58% | B.萊利證券 | $42 → $42 | 升級 | 中性→購買 |
| 08/08/2018 | 5223.74% | 貝爾德 | → $74 | 開始承保 | →跑贏大盤 |
| 05/08/2018 | 2921.58% | B.萊利證券 | $45 → $42 | 維護 | 中性 |
| 04/13/2018 | — | 查爾丹資本 | 評級下調 | 購買→中性 | |
| 01/05/2018 | 2417.99% | B.萊利證券 | → $35 | 開始承保 | →中性 |
What is the target price for Assembly Biosciences (ASMB)?
組裝生物科學(ASMB)的目標價格是多少？
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by Mizuho on November 16, 2022. The analyst firm set a price target for $3.00 expecting ASMB to rise to within 12 months (a possible 115.83% upside). 3 analyst firms have reported ratings in the last year.
瑞穗於2022年11月16日報道了組裝生物科學公司(納斯達克代碼：ASMB)的最新目標價。這家分析公司將目標價定為3美元，預計ASMB將在12個月內上漲至(可能上漲115.83%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Assembly Biosciences (ASMB)?
組裝生物科學(ASMB)的最新分析師評級是多少？
The latest analyst rating for Assembly Biosciences (NASDAQ: ASMB) was provided by Mizuho, and Assembly Biosciences maintained their buy rating.
瑞穗對Assembly Biosciences(納斯達克代碼：ASMB)的最新分析師評級為買入，Assembly Biosciences維持買入評級。
When is the next analyst rating going to be posted or updated for Assembly Biosciences (ASMB)?
組裝生物科學(ASMB)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Assembly Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Assembly Biosciences was filed on November 16, 2022 so you should expect the next rating to be made available sometime around November 16, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閲公共財務報表，與Assembly Biosciences的高管和客户交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。組裝生物科學的最後一次評級是在2022年11月16日提交的，所以你應該預計下一次評級將在2023年11月16日左右的某個時候提供。
Is the Analyst Rating Assembly Biosciences (ASMB) correct?
分析師對組裝生物科學(ASMB)的評級正確嗎？
While ratings are subjective and will change, the latest Assembly Biosciences (ASMB) rating was a maintained with a price target of $14.00 to $3.00. The current price Assembly Biosciences (ASMB) is trading at is $1.39, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的組裝生物科學(ASMB)評級保持不變，目標價在14.00美元至3.00美元之間。Assembly Biosciences(ASMB)目前的交易價格為1.39美元，超出了分析師的預測範圍。